Beacon Investment Advisory Services, Inc. Invitae Corp Transaction History

Beacon Investment Advisory Services, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 13, 2023	SELL	$1.71 - $3.61 $5,586 - $11,793	-3,267 Reduced 23.5%	10,635 $0
Q3 2022 Oct 20, 2022	SELL	$1.9 - $8.63 $1,734 - $7,879	-913 Reduced 6.16%	13,902 $34,000
Q2 2022 Jul 21, 2022	BUY	$2.13 - $9.01 $749 - $3,171	352 Added 2.43%	14,815 $36,000
Q1 2022 May 12, 2022	SELL	$6.28 - $15.59 $3,253 - $8,075	-518 Reduced 3.46%	14,463 $116,000
Q4 2021 Feb 04, 2022	BUY	$14.7 - $28.67 $1,073 - $2,092	73 Added 0.49%	14,981 $229,000

Q3 2021 Nov 09, 2021	BUY	$24.31 - $33.6 $74,777 - $103,353	3,076 Added 26.0%	14,908 $424,000
Q2 2021 Aug 02, 2021	BUY	$26.09 - $40.4 $107,803 - $166,932	4,132 Added 53.66%	11,832 $399,000
Q1 2021 May 21, 2021	BUY	$33.06 - $56.93 $254,562 - $438,361	7,700 New	7,700 $294,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Beacon Investment Advisory Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Beacon Investment Advisory Services, Inc. with notifications on news.